Tuning Ligand Density To Optimize Pharmacokinetics of Targeted Nanoparticles for Dual Protection against Tumor-Induced Bone Destruction-Reference-Cited by-同舟云学术

Tuning Ligand Density To Optimize Pharmacokinetics of Targeted Nanoparticles for Dual Protection against Tumor-Induced Bone Destruction

Published:2020-01-02 Issue:1 Volume:14 Page:311-327
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Vanderburgh Joseph¹²³,Hill Jordan L.⁴,Gupta Mukesh K.⁴,Kwakwa Kristin A.²³⁵,Wang Sean K.⁴,Moyer Kathleen⁶,Bedingfield Sean K.⁴,Merkel Alyssa R.²³,d’Arcy Richard⁴,Guelcher Scott A.¹²⁴^ORCID,Rhoades Julie A.²³⁴⁷,Duvall Craig L.⁴^ORCID

Affiliation:

1. Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States

2. Center for Bone Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States

3. Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee 37212, United States

4. Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States

5. Program in Cancer Biology, Vanderbilt University, Nashville, Tennessee 37232, United States

6. Interdisciplinary Graduate Program in Materials Science, Vanderbilt University, Nashville, Tennessee 37232, United States

7. Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States

Funder

National Cancer Institute

U.S. Department of Veterans Affairs

Congressionally Directed Medical Research Programs

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.9b04571

Reference84 articles.

1. Mechanisms of Bone Metastasis

2. Future directions of bone-targeted therapy for metastatic breast cancer

3. Denosumab and bisphosphonates: Different mechanisms of action and effects

4. High-Dose Zoledronic Acid Impacts Bone Remodeling with Effects on Osteoblastic Lineage and Bone Mechanical Properties

5. Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell encapsulation systems for probiotic delivery: Armor probiotics;Advances in Colloid and Interface Science;2024-10

2. Pharmacologic Hedgehog inhibition modulates the cytokine profile of osteolytic breast cancer cells;Journal of Bone Oncology;2024-08

3. Targeted delivery of anti-osteoporosis therapy: Bisphosphonate-modified nanosystems and composites;Biomedicine & Pharmacotherapy;2024-06

4. Mg alloys with antitumor and anticorrosion properties for orthopedic oncology: A review from mechanisms to application strategies;APL Bioengineering;2024-04-17

5. Advancing Bone-Targeted Drug Delivery: Leveraging Biological Factors and Nanoparticle Designs to Improve Therapeutic Efficacy;ACS Biomaterials Science & Engineering;2024-03-27